臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :2875249
	造訪人次 : 54225396 線上人數 : 1095 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pu y s"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 511-520 / 627 (共63頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-04-28T07:25:34Z	Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study	Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S.
臺大學術典藏	2020-04-28T07:25:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2020-04-28T07:25:32Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2020-04-28T07:25:28Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.
臺大學術典藏	2020-04-28T07:25:14Z	A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement	Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2020-04-27T08:45:14Z	Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells	Tsai Y.-C.;Ho P.-Y.;Tzen K.-Y.;Tuan T.-F.;Liu W.-L.;Cheng A.-L.;Pu Y.-S.;Chia-Hsien Cheng; Tsai Y.-C.; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; CHIA-HSIEN CHENG
臺大學術典藏	2020-04-27T08:45:09Z	Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center	Hong J.-H.;Lin Y.-H.;Lu Y.-C.;Chiang Y.;Tai H.-C.;Huang K.-H.;Chia-Hsien Cheng;Pu Y.-S.; Huang K.-H.; CHIA-HSIEN CHENG; Pu Y.-S.; Tai H.-C.; Hong J.-H.; Lin Y.-H.; Lu Y.-C.; Chiang Y.
臺大學術典藏	2020-04-27T08:45:09Z	A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement	Chiang Y.;Chia-Hsien Cheng;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; CHIA-HSIEN CHENG; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2020-03-27T05:28:59Z	Emphysematous pyelonephritis: Clinical characteristics and prognostic factors	Pong Y.-H.; Chen C.-H.; Pu Y.-S.; PO-REN HSUEH; Huang C.-Y.; Chiang B.-J.; Lu Y.-C.; Huang C.-Y.;PO-REN HSUEH;Pu Y.-S.;Chen C.-H.;Pong Y.-H.;Chiang B.-J.;Lu Y.-C.
臺大學術典藏	2020-03-27T05:28:58Z	Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis	Chiang B.-J.; Pong Y.-H.; Huang K.-H.; PO-REN HSUEH; Huang C.-Y.; Pu Y.-S.; Lu Y.-C.; Pu Y.-S.;Huang C.-Y.;PO-REN HSUEH;Huang K.-H.;Pong Y.-H.;Chiang B.-J.;Lu Y.-C.

顯示項目 511-520 / 627 (共63頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目